120 related articles for article (PubMed ID: 37867445)
1. Fraxetin inhibits proliferation and induces apoptosis of bladder cancer through the Akt pathway in vitro and in vivo.
Weng M; Deng Z; Huang S; Lin X; Xu N; Sun X; Wu W; Lu J; Wang D
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23556. PubMed ID: 37867445
[TBL] [Abstract][Full Text] [Related]
2. Fraxetin down-regulates polo-like kinase 4 (PLK4) to inhibit proliferation, migration and invasion of prostate cancer cells through the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathway.
Ma Z; Sun Y; Peng W
Bioengineered; 2022 Apr; 13(4):9345-9356. PubMed ID: 35387563
[TBL] [Abstract][Full Text] [Related]
3. Fraxetin inhibits the growth of colon adenocarcinoma cells via the Janus kinase 2/signal transducer and activator of transcription 3 signalling pathway.
Ren S; Xing Y; Wang C; Jiang F; Liu G; Li Z; Jiang T; Zhu Y; Piao D
Int J Biochem Cell Biol; 2020 Aug; 125():105777. PubMed ID: 32504672
[TBL] [Abstract][Full Text] [Related]
4. Fraxetin suppresses reactive oxygen species-dependent autophagy by the PI3K/Akt pathway to inhibit isoflurane-induced neurotoxicity in hippocampal neuronal cells.
Zhang T; Zhou B; Sun J; Song J; Nie L; Zhu K
J Appl Toxicol; 2022 Apr; 42(4):617-628. PubMed ID: 34553399
[TBL] [Abstract][Full Text] [Related]
5. Exploring the mechanism of fraxetin against acute myeloid leukemia through cell experiments and network pharmacology.
Fang T; Liu L; Liu W
BMC Complement Med Ther; 2024 Jun; 24(1):226. PubMed ID: 38858650
[TBL] [Abstract][Full Text] [Related]
6. Flavagline analog FL3 induces cell cycle arrest in urothelial carcinoma cell of the bladder by inhibiting the Akt/PHB interaction to activate the GADD45α pathway.
Yuan G; Chen X; Liu Z; Wei W; Shu Q; Abou-Hamdan H; Jiang L; Li X; Chen R; Désaubry L; Zhou F; Xie D
J Exp Clin Cancer Res; 2018 Feb; 37(1):21. PubMed ID: 29415747
[TBL] [Abstract][Full Text] [Related]
7. PPARγ activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway.
Lv S; Wang W; Wang H; Zhu Y; Lei C
BMC Cancer; 2019 Mar; 19(1):204. PubMed ID: 30845932
[TBL] [Abstract][Full Text] [Related]
8. Metformin exerts an antitumor effect by inhibiting bladder cancer cell migration and growth, and promoting apoptosis through the PI3K/AKT/mTOR pathway.
Shen Z; Xue D; Wang K; Zhang F; Shi J; Jia B; Yang D; Zhang Q; Zhang S; Jiang H; Luo D; Li X; Zhong Q; Zhang J; Peng Z; Han Y; Sima C; He X; Hao L
BMC Urol; 2022 May; 22(1):79. PubMed ID: 35610639
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between the inhibitory effect of fraxetin on breast cancer and estrogen signaling pathway].
Huo HN; Xie KP; Wang LM; Jiang Y; Zou W; Xie MJ
Sheng Li Xue Bao; 2013 Jun; 65(3):323-8. PubMed ID: 23788190
[TBL] [Abstract][Full Text] [Related]
10. Andrographolide Inhibits Proliferation and Promotes Apoptosis in Bladder Cancer Cells by Interfering with NF- κ B and PI3K/AKT Signaling In Vitro and In Vivo.
Xuan L; Hu JH; Bi R; Liu SQ; Wang CX
Chin J Integr Med; 2022 Apr; 28(4):349-356. PubMed ID: 35048242
[TBL] [Abstract][Full Text] [Related]
11. The Role of Specificity Protein 1 (SP1) in Bladder Cancer Progression through PTEN-Mediated AKT/mTOR Pathway.
Chen Z
Urol Int; 2023; 107(9):848-856. PubMed ID: 37666229
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of TRIM26 inhibits the proliferation, migration and invasion of bladder cancer cells through the Akt/GSK3β/β-catenin pathway.
Xie X; Li H; Pan J; Han X
Chem Biol Interact; 2021 Mar; 337():109366. PubMed ID: 33549581
[TBL] [Abstract][Full Text] [Related]
13. SC66 inhibits the proliferation and induces apoptosis of human bladder cancer cells by targeting the AKT/β-catenin pathway.
Chen W; Zhao S; Yu W; Rao T; Ruan Y; Zhu S; Xia Y; Song H; Cheng F
J Cell Mol Med; 2021 Nov; 25(22):10684-10697. PubMed ID: 34687144
[TBL] [Abstract][Full Text] [Related]
14. Isofraxidin inhibited proliferation and induced apoptosis via blockage of Akt pathway in human colorectal cancer cells.
Shen P; Wang HG; Li MM; Ma QY; Zhou CW; Pan F; Xie R
Biomed Pharmacother; 2017 Aug; 92():78-85. PubMed ID: 28531803
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA HULC promotes bladder cancer cells proliferation but inhibits apoptosis via regulation of ZIC2 and PI3K/AKT signaling pathway.
Wang J; Ma W; Liu Y
Cancer Biomark; 2017 Dec; 20(4):425-434. PubMed ID: 28946549
[TBL] [Abstract][Full Text] [Related]
16. Oridonin Promotes Apoptosis and Restrains the Viability and Migration of Bladder Cancer by Impeding TRPM7 Expression via the ERK and AKT Signaling Pathways.
Che X; Zhan J; Zhao F; Zhong Z; Chen M; Han R; Wang Y
Biomed Res Int; 2021; 2021():4340950. PubMed ID: 34285910
[TBL] [Abstract][Full Text] [Related]
17. Leflunomide Inhibits Proliferation and Induces Apoptosis via Suppressing Autophagy and PI3K/Akt Signaling Pathway in Human Bladder Cancer Cells.
Cheng L; Wang H; Wang Z; Huang H; Zhuo D; Lin J
Drug Des Devel Ther; 2020; 14():1897-1908. PubMed ID: 32546957
[TBL] [Abstract][Full Text] [Related]
18. Sialidase NEU1 suppresses progression of human bladder cancer cells by inhibiting fibronectin-integrin α5β1 interaction and Akt signaling pathway.
Zhou X; Zhai Y; Liu C; Yang G; Guo J; Li G; Sun C; Qi X; Li X; Guan F
Cell Commun Signal; 2020 Mar; 18(1):44. PubMed ID: 32164705
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.
Liang Z; Wang X; Xu X; Xie B; Ji A; Meng S; Li S; Zhu Y; Wu J; Hu Z; Lin Y; Zheng X; Xie L; Liu B
Mol Cancer; 2017 May; 16(1):96. PubMed ID: 28549468
[TBL] [Abstract][Full Text] [Related]
20. Isoquercitrin inhibits bladder cancer progression in vivo and in vitro by regulating the PI3K/Akt and PKC signaling pathways.
Chen F; Chen X; Yang D; Che X; Wang J; Li X; Zhang Z; Wang Q; Zheng W; Wang L; Wang X; Song X
Oncol Rep; 2016 Jul; 36(1):165-72. PubMed ID: 27177091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
